Clinical Trial

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Name: First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma — clinical trial record (NCT06797999)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADCElerate1

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2025-01-22; most recent amendment 2026-01-27.

Status change: Not Yet Recruiting → Recruiting 2025-04-25

Trial Details

NCT Number	NCT06797999
Lead Sponsor	Adcendo ApS
Conditions	Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
Enrollment	270 participants
Start Date	2025-06-05
Primary Completion	2029-02-27 (estimated)
Study Completion	2029-02-27 (estimated)
Updated on ClinicalTrials.gov	2026-01-28